Main > A1. CORP. INDEX. K-Km > Kala Pharmaceuticals Inc./P C2
This data is not available for free
Kala Pharmaceuticals Inc./P C2's subsections
2012. 03.14. Equity Financing
2012. 07.12. Pres. & CEO
2013. 02.28. Equity Financing
2014. 04.23. B Financing
2018. 08.23. FDA Approval
2020. 10.27. Dry Eye DIS.>USA>OK
2021. 01.07. Dry Eye DIS.>USA>Launc
2022. 05.23. Alcon
2022. 07.11. Alcon
2023. 08.02. Name Change To
Web-Site
Kala Pharmaceuticals Inc./P C2's products
This section has no products